Anagram Therapeutics's $250M: A Big Biotech Bet Amid AI's Spotlight
Anagram Therapeutics raised $250M in May 2026, one of the largest biotech rounds of the period, proving life-sciences capital is alive alongside AI.
Venture Capital Market Analysis & Investment Trends
Understanding venture capital market dynamics helps founders time their raises and helps investors spot durable themes. Our market analysis covers deal flow, sector concentration, valuation benchmarks, and geographic shifts across the global startup ecosystem.
What Our Market Analysis Covers
- Deal volume & sizing: Round counts, median check sizes, and mega-round activity
- Sector allocation: Where capital is flowing — and where it's pulling back
- Valuation trends: Reset dynamics, revenue multiples, and late-stage pricing
- Regional comparisons: NYC vs. SF, Europe, Asia, and emerging hubs
Browse market analysis articles for data-driven insight into venture capital trends.
Related Articles (184 articles)
Astranis's $455M: Small GEO Satellites for Affordable Connectivity
Astranis raised $455M in May 2026 to scale its small geostationary satellites, bringing dedicated connectivity to underserved regions and customers.
Astrocade's $56M: Sequoia and Sea Bet on AI-Generated Games
Astrocade raised $56M across a Sequoia-led Series B and a Sea-led Series A in May 2026, building an AI platform for creating games.
Blitzy's $200M at $1.4B: Autonomous Software Development Scales
Blitzy raised $200M at a $1.4B valuation in May 2026, led by Northzone, as autonomous software-development platforms attract serious capital.
DeepInfra's $107M Series B: Cheaper, Faster Model Inference at Scale
DeepInfra raised $107M Series B in May 2026 to scale low-cost, high-throughput AI inference infrastructure for developers and enterprises.
Reserv's $125M: AI-Native Claims Handling Attracts Big Capital
Reserv raised $125M in May 2026 to scale its AI-driven claims-handling platform, part of the broader insurtech-meets-AI funding wave.